首页>投融资
ProSomnus
退市
ProSomnus, Inc.于2016年3月在特拉华州注册成立。他们是一家医疗技术公司,专注于开发、制造和销售精密口内医疗设备,这是一种治疗和管理轻度至中度阻塞性睡眠呼吸暂停(OSA)患者的新选择。每个ProSomnus精密口内器械都是根据每个病人的解剖结构和治疗计划个性化的。他们获得专利的精密设备经过精心设计,创造出独特、一致和可预测的生物力学优势,为OSA患者带来有效、舒适、经济和患者偏好的治疗结果。
基本信息
-
公司全称Prosomnus Inc
-
类型
-
产业领域医疗器械、治疗设备
-
公司人数101~500人
-
地址5675 Gibraltar Drive Pleasanton CA 94588
-
联系电话
-
邮箱
-
成立时间
投融资
-
2024-04-17退市未透露未透露
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司,该公司开发了一种先进的放疗平台,能够对不可切除的实体瘤和手术切缘进行局部靶向治疗,称为YntraDose。